NantHealth, Inc. [NH] Stock Forecast

Q: What is NantHealth, Inc. stock symbol ?

NantHealth, Inc. is a US stock, located in Morrisville of Nc and trading under the symbol NH

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

NH Stock Summary

Earnings have grown 6.95% per last year.

The Moving Average Convergence Divergence (MACD) for NH recently turned positive (within last 10 days).

NH has more than 6 years of cash runway (80 months)

Earnings are expected to fall -100% next year

Does not have any significance market cap ($10.4M)

In the News

NH Financial details

Company Rating

Neutral

Market Cap

10.4M

Income

-70.37M

Revenue

64.27M

Book val./share

-16.67

Cash/share

0.39

Dividend

Dividend %

Employees

365

Optionable

Shortable

Yes

Earnings

02 Aug 2023

P/E

-0.16

Forward P/E

PEG

-0.25

P/S

0.15

P/B

-0.04

P/C

3.46

P/FCF

-0.3

Quick Ratio

0.56

Current Ratio

0.64

Debt / Equity

-0.39

LT Debt / Equity

-0.01

EPS (TTM)

-8.19

EPS next Y

EPS next Q

EPS this Y

14.29%

EPS next Y

EPS next 5Y

EPS last 5Y

-19.59%

Revenue last 5Y

-5.62%

Revenue Q/Q

-27.74%

EPS Q/Q

-55.95%

SMA20

SMA50

SMA100

Inst Own

0.01%

Inst Trans

ROA

-38%

ROE

30%

ROC

-0.39%

Gross Margin

59%

Oper. Margin

-75%

Profit Margin

-95%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

0.8505-9.749999

52W High

52W Low

RSI

Rel Volume

3.91

Avg Volume

50.67K

Volume

197.97K

Perf Week

Perf Month

Perf Quarter

Perf Half Y

Beta

1.82442

Volatility

0%, 0%

Prev Close

Price

1.35

Change

-34.15%

NH Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	12.29	13.03	9.89	8.23	8.7
Net income per share	-26.17	-8.51	-11.96	-7.7	-8.8
Operating cash flow per share	-4.07	-1.19	-2.28	-3.64	-4.19
Free cash flow per share	-5.52	-1.81	-3.05	-4.31	-5.03
Cash per share	2.52	0.71	3.08	3.82	0.23
Book value per share	0.39	-7.76	-15.11	-21.29	-29.26
Tangible book value per share	-24.43	-30.54	-34.84	-39.34	-45.94
Share holders equity per share	0.39	-7.76	-15.11	-21.29	-29.26
Interest debt per share	29.9	31.97	32.49	35.62	36.55
Market cap	59.41M	113.78M	358.38M	120.43M	28.12M
Enterprise value	241.58M	325.97M	556.69M	347.91M	293.76M
P/E ratio	-0.31	-1.82	-4.05	-2.06	-0.41
Price to sales ratio	0.66	1.19	4.9	1.92	0.42
POCF ratio	-2	-12.98	-21.26	-4.35	-0.87
PFCF ratio	-1.48	-8.52	-15.91	-3.67	-0.73
P/B Ratio	20.99	-1.99	-3.21	-0.74	-0.12
PTB ratio	20.99	-1.99	-3.21	-0.74	-0.12
EV to sales	2.7	3.4	7.61	5.55	4.38
Enterprise value over EBITDA	-1.4	-8.93	-8.65	-8.69	-7.73
EV to operating cash flow	-8.15	-37.19	-33.03	-12.56	-9.1
EV to free cash flow	-6.01	-24.41	-24.71	-10.62	-7.58
Earnings yield	-3.21	-0.55	-0.25	-0.49	-2.41
Free cash flow yield	-0.68	-0.12	-0.06	-0.27	-1.38
Debt to equity	70.81	-3.81	-1.98	-1.58	-1.19
Debt to assets	0.7	0.82	1.1	1.3	1.68
Net debt to EBITDA	-1.05	-5.81	-3.08	-5.68	-6.99
Current ratio	1.08	0.66	0.25	1.41	0.35
Interest coverage	-2.96	-1.48	-1.33	-2.82	-3.64
Income quality	0.15	0.14	0.3	0.47	0.48
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.23	0.2	0.24	0.31	0.34
Intangibles to total assets	0.63	0.63	0.73	0.69	0.81
Capex to operating cash flow	0.36	0.52	0.34	0.18	0.2
Capex to revenue	-0.12	-0.05	-0.08	-0.08	-0.1
Capex to depreciation	-0.47	-0.21	-0.34	-0.32	-0.4
Stock based compensation to revenue	0.06	0.03	0.04	0.06	0.07
Graham number	15.13	38.53	63.76	60.71	76.11
ROIC	-0.24	-0.16	-0.22	-0.41	-1.06
Return on tangible assets	-1.8	-0.63	-1.64	-0.97	-2.18
Graham Net	-34.73	-41.98	-38.62	-42.84	-48.82
Working capital	2.91M	-19.59M	-94.16M	11.47M	-23.05M
Tangible asset value	-177.8M	-224.91M	-257.7M	-299.36M	-353.84M
Net current asset value	-244.06M	-285.71M	-281.09M	-320.41M	-372.36M
Invested capital	70.81	-3.81	-1.98	-1.58	-1.19
Average receivables	14.18M	14.02M	8.02M	5.31M	7M
Average payables	2.41M	2.8M	4.54M	4.16M	6.81M
Average inventory	667.5K	647K	399K	0	1.38M
Days sales outstanding	66.47	44.66	21.47	36.8	41.8
Days payables outstanding	13.6	37.53	63.97	42.06	131.73
Days of inventory on hand	4.09	7.58	0	0	34.86
Receivables turnover	5.49	8.17	17	9.92	8.73
Payables turnover	26.83	9.72	5.71	8.68	2.77
Inventory turnover	89.25	48.15	0	0	10.47
ROE	-67.27	1.1	0.79	0.36	0.3
Capex per share	-1.45	-0.62	-0.77	-0.67	-0.84

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric	2022-09-30	2022-12-31	2023-03-31	2023-06-30	2023-09-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	2.16	2.27	2.21	2.24	0.83
Net income per share	-1.77	-3.33	-1.59	-2.27	-1
Operating cash flow per share	-0.65	-0.91	-0.85	0	0
Free cash flow per share	-0.82	-1.22	-1.02	0	0
Cash per share	0.08	0.23	1.84	0.8	0.39
Book value per share	-26.11	-29.26	-30.72	-32.87	-16.67
Tangible book value per share	-43.08	-45.94	-47.25	-49.26	-24.89
Share holders equity per share	-26.11	-29.26	-30.72	-32.87	-16.67
Interest debt per share	33.86	35.19	37.86	12.18	6.23
Market cap	28.46M	28.12M	15.41M	10.4M	20.26M
Enterprise value	285.18M	293.76M	288.74M	102.82M	112.77M
P/E ratio	-0.52	-0.27	-0.31	-0.15	-0.34
Price to sales ratio	1.71	1.61	0.9	0.6	1.63
POCF ratio	-5.66	-3.99	-2.34	0	0
PFCF ratio	-4.5	-3	-1.97	0	0
P/B Ratio	-0.14	-0.12	-0.07	-0.04	-0.08
PTB ratio	-0.14	-0.12	-0.07	-0.04	-0.08
EV to sales	17.15	16.79	16.93	5.96	9.04
Enterprise value over EBITDA	-46.44	-16.15	-56.98	-11.78	-10.73
EV to operating cash flow	-56.76	-41.69	-43.93	0	0
EV to free cash flow	-45.13	-31.38	-36.85	0	0
Earnings yield	-0.48	-0.91	-0.79	-1.68	-0.74
Free cash flow yield	-0.22	-0.33	-0.51	0	0
Debt to equity	-1.28	-1.19	-1.21	-0.39	-0.39
Debt to assets	1.6	1.68	1.7	0.63	0.67
Net debt to EBITDA	-41.8	-14.6	-53.94	-10.59	-8.8
Current ratio	0.36	0.35	0.64	0.25	0.08
Interest coverage	-4.03	-3.52	-2.94	1.82	2.16
Income quality	0.37	0.27	0.54	0	0
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.38	0.3	0.3	0.39	0.19
Intangibles to total assets	0.81	0.81	0.75	0.8	0.84
Capex to operating cash flow	0.26	0.33	0.19	0	0
Capex to revenue	-0.08	-0.13	-0.07	0	0
Capex to depreciation	-0.32	-0.57	-0.43	0	0
Stock based compensation to revenue	0.05	0.06	0.05	0	0
Graham number	32.27	46.83	33.14	40.97	19.35
ROIC	-0.23	-0.27	-0.22	0.06	0.07
Return on tangible assets	-0.45	-0.82	-0.29	-0.56	-0.65
Graham Net	-45.98	-48.82	-49.99	-51.88	-25.81
Working capital	-21.44M	-23.05M	-13.67M	-44.23M	-175.76M
Tangible asset value	-331.84M	-353.84M	-364M	-379.5M	-373.64M
Net current asset value	-349.93M	-372.36M	-381.43M	-395.66M	-381.32M
Invested capital	-1.28	-1.19	-1.21	-0.39	-0.39
Average receivables	6.28M	7.35M	7.44M	6.85M	5.53M
Average payables	5.53M	8.31M	10.09M	7.98M	6.44M
Average inventory	3.62M	3.38M	2.88M	1.5M	0
Days sales outstanding	38.01	39.47	38.05	33.87	33.03
Days payables outstanding	80.75	126.84	136.74	97.82	110.98
Days of inventory on hand	52.05	33.56	42.07	0	0
Receivables turnover	2.37	2.28	2.37	2.66	2.72
Payables turnover	1.11	0.71	0.66	0.92	0.81
Inventory turnover	1.73	2.68	2.14	0	0
ROE	0.07	0.11	0.05	0.07	0.06
Capex per share	-0.17	-0.3	-0.16	0	0

NH Frequently Asked Questions

What is NantHealth, Inc. stock symbol ?

NantHealth, Inc. is a US stock , located in Morrisville of Nc and trading under the symbol NH

What is NantHealth, Inc. stock quote today ?

NantHealth, Inc. stock price is $1.35 today.

Is NantHealth, Inc. stock public?

Yes, NantHealth, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Check Those

Similar Market Cap

Company Profile

Volume Average 50.67K
Market Capitalization 10.4M
Employee 365
CEO Dr. Patrick Soon-Shiong F.A.C.S., FACS, FRCS (C), M.Sc.
Headquarters Morrisville,NC,US
IPO Date 2016-06-02
Website https://nanthealth.com

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.